Physician profile
Lauren Marie Metterle
NPI 1033572391
$1,669.57
in general payments reported to CMS, 2019-2025
17 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Pediatric Dermatology provider received nationally (typical 2025 total: $302).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $37.93 · 2021: $123 · 2022: $564 · 2023: $191 · 2024: $146 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $432.42 | 2019-2025 | |
| Allergan, INC. | $220.03 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $176.29 | 2022-2024 | |
| Pfizer INC. | $127.59 | 2020-2025 | |
| Kyowa Kirin, INC. | $119.15 | 2019 | |
| Amgen INC. | $93.33 | 2023-2025 | Otezla, Otezla |
| Genzyme Corporation | $85.59 | 2022-2023 | |
| Incyte Corporation | $71.09 | 2022-2023 | Opzelura |
| Nobelpharma America, LLC | $61.59 | 2022-2024 | |
| Almirall LLC | $59.96 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $55.61 | 2025 | Dupixent |
| Galderma Laboratories, L.P. | $51.57 | 2022-2024 | Dysport |
| Ucb, INC. | $34.51 | 2025 | Bimzelx |
| Organon LLC | $33.38 | 2025 | |
| Pierre Fabre Pharmaceuticals, INC. | $17.23 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $15.74 | 2023 | |
| Janssen Biotech, INC. | $14.49 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Metterle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.